☆ 4.4 Editorial Material

HDAC inhibitors in liver cancer: which route to take?

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2019)

Get Full Text
Add to Collection

Journal

EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY
Volume 13, Issue 6, Pages 515-517

Publisher

TAYLOR & FRANCIS LTD
DOI: 10.1080/17474124.2019.1605289

Keywords

Hepatocellular carcinoma; epigenetics; histone acetylation; histone deacetylase inhibitor; drug combination

Categories

Gastroenterology & Hepatology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.